info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » healthcare

Healthcare

Radiotheranostics Market By Product Type (Radiopharmaceuticals, Diagnostic Imaging Systems, Radiotherapy Systems); By Application (Oncology, Cardiology, Neurology, Others); By End User (Hospitals & Cancer Treatment Centers, Diagnostic Imaging Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Radiotheranostics Market valued at USD 6.7 billion in 2024 and forecast to reach USD 14.1 billion by 2030 with 10.5% CAGR, led by precision medici... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

P2X7 Receptor Antagonists Market By Product Type (Oral Small Molecules, Injectable Biologics, Others); By Application (Rheumatoid Arthritis, Neuropathic Pain, Inflammatory Bowel Disease, ALS, Alzheimer’s Disease, Others); By End User (Hospitals, Specialty Clinics, Community Clinics, Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

P2X7 Receptor Antagonists Market Searches for Clinical Proof in Neuroinflammation (Last Updated on: June-2026)

The Global P2X7 Receptor Antagonists Market will witness a robust CAGR of 8.1%, valued at USD 614.5 million in 2024, and i... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Metoprolol Tartrate Market By Formulation (Oral, Injectable); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Metoprolol Tartrate Market is set for steady expansion, with an estimated value of USD 2.6 billion in 2024 and a projected increase to nearly USD 3.5 billion by 2030, refl... Read More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Ovo-Sexing Technology Market By Technology (Spectroscopy-Based, Genetic Marker Analysis, AI-Driven Imaging, VOC Analysis); By Application (Layer Hatcheries, Broiler Hatcheries, Research Facilities); By End User (Commercial Hatcheries, Animal Welfare Startups, Government/Public Hatcheries); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ovo-Sexing Technology Market forecast to hit USD 580 million by 2030 from USD 210 million in 2024 with CAGR of 18.1%, boosted by poultry industry ... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Arterial Blood Gas Kits Market By Product Type (Syringe-Based Kits, Capillary Kits, Pre-Heparinized Kits, Point-of-Care ABG Cartridges); By End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Arterial Blood Gas (ABG) Kits Market reaches USD 927.6 million by 2030 from USD 612.4 million in 2024 at 6.1% CAGR, driven by blood gas analysisRead More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Trastuzumab Emtansine Market By Indication (HER2-Positive Breast Cancer, HER2-Positive Gastric Cancer, Other HER2 Tumors); By Route of Administration (Intravenous); By Distribution Channel (Hospital Pharmacies, Specialty Cancer Centers, Clinical Trial Networks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Trastuzumab Emtansine Market is projected to grow at a CAGR of 6.8%, reaching USD 3.6 billion by 2030, up from USD 2.4 billion in 2024, supported by deman... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Syphilis Immunoassay Diagnostics Market By Product Type (Laboratory-based Immunoassays, Rapid Point-of-Care Immunoassays); By Technology (ELISA, CLIA, FIA, Lateral Flow Immunoassays); By Sample Type (Serum, Plasma, Whole Blood, Fingerstick); By End User (Hospitals, Reference Laboratories, Public Health Agencies, Clinics, NGOs); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Syphilis Immunoassay Diagnostics Market estimated at USD 2.1 billion in 2024 is expected to climb to USD 3.1 billion by 2030 with 6.7% CAGR, driven by Read More

Published Date: JAN-2026 | No Of Pages:198 | $ 4485

Cell Line Development Serum Market By Product Type (Fetal Bovine Serum, Human Serum, Animal-Free Alternatives); By Application (Biopharmaceutical Production, Stem Cell Research, Vaccine Development, Gene Therapy); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs/CDMOs, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cell Line Development Serum Market valued at USD 1.9 billion in 2024 and projected to reach USD 3.0 billion by 2030, expanding at 8.1%, CAGR, supported by... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Pertuzumab Market By Indication (HER2-Positive Breast Cancer, HER2-Positive Gastric Cancer); By Route of Administration (Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pertuzumab Market growing from USD 2.8 billion in 2024 to USD 4.1 billion by 2030 with a CAGR of 6.5%, supported by monoclonal antibody, ... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Halal Empty Capsules Market By Product Type (Gelatin-Based, Non-Gelatin [HPMC, Pullulan, Others]); By Capsule Size/Form (00, 0, 1, 2, 3, 4, 5, Specialty Forms); By End User (Pharmaceutical Manufacturers, Nutraceutical Companies, Contract Manufacturers); By Distribution Channel (Direct Supply, Distributors, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Halal Empty Capsules Market valued at USD 1.2 billion in 2024 and projected to reach USD 1.85 billion by 2030 at 6.8%, CAGR, led by pharmaceutical... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Pollen Allergy Market By Treatment Type (Pharmacotherapy, Immunotherapy [SCIT, SLIT], Biologic Therapies); By Route of Administration (Oral, Nasal, Injectable); By Distribution Channel (Hospital & Allergy Clinics, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pollen Allergy Market is projected to grow at a steady CAGR of 5.8%, valued at USD 8.9 billion in 2024, and anticipated to reach USD 12.5 billion by 2030,... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Ventilator Associated Pneumonia Market By Product Type (Endotracheal Tubes [Standard, Antimicrobial-Coated], Closed Suction Systems, Heat and Moisture Exchangers, Oral Care Kits, Humidification Devices); By Diagnostic Method (Culture-Based, Molecular Diagnostics, Bronchoalveolar Lavage, CPIS Assessment); By End User (Tertiary Hospitals, Private Multispecialty Hospitals, LTACs, Military Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ventilator Associated Pneumonia Market will witness a robust CAGR of 7.4%, valued at USD 2.1 billion in 2024, expected to appreciate and reach USD 3.5 billion by 2... Read More

Published Date: JAN-2026 | No Of Pages:196 | $ 4485

Pemphigus Vulgaris Market By Treatment Type (Corticosteroids, Immunosuppressants, Monoclonal Antibodies, Small Molecules); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pemphigus Vulgaris Market is forecast to grow at a CAGR of 6.5%, increasing from USD 708 million in 2024 to USD 1.04 billion by 2030, driven by bi... Read More

Published Date: JAN-2026 | No Of Pages:198 | $ 4485

Vectorized Antibodies for In Vivo Expression Market By Delivery Vector (mRNA-based Vectors, AAV & Viral Vectors, DNA Plasmids & Synthetic Systems); By Therapeutic Application (Infectious Diseases, Oncology, Rare Genetic Disorders, Autoimmune Diseases); By End User (Biopharma Companies, Academic Research Centers, Public Health Agencies, Military Health Systems); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vectorized Antibodies For In Vivo Expression Market valued at USD 3.2 billion in 2024 and expected to hit USD 6.2 billion by 2030 at 11.7% CAGR, driven by... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

On-Body Drug Delivery Devices Market By Product Type (Prefilled On-Body Injectors, Fillable/Customizable On-Body Systems); By Therapy Area (Autoimmune Disorders, Oncology, Diabetes, Cardiovascular & Metabolic Diseases, Others); By End User (Home Care Settings, Hospitals & Infusion Centers, Specialty Clinics, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global On-Body Drug Delivery Devices Market will witness a steady CAGR of 7.8 %, valued at USD 5.2 billion in 2024, and expected to reach USD 8.16 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Dental Bearings Market By Product Type (Ball Bearings, Roller Bearings, Others); By Material (Stainless Steel, Ceramic, Hybrid, Others); By Application (Dental Handpieces, Dental Motors, Others); By End User (Dental Clinics, Hospitals, Dental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dental Bearings Market valued at $350 million in 2024 and expected to reach $525 million by 2030 at CAGR of 6.8%, driven by dental equipment techn... Read More

Published Date: JAN-2026 | No Of Pages:198 | $ 4485

Viral Clearance Market By Product Type (Viral Filtration Systems, Chromatography-based Viral Clearance, Inactivation Agents); By Application (Gene Therapy, Biologics, Vaccines, Blood and Plasma Products); By End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, Research and Academic Institutions, Blood and Plasma Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Viral Clearance Market is fueled by biopharmaceutical purification, viral safety validation, bioprocess filtration, monoclonal antibody production... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Undescended Testicle Market By Treatment Type (Surgery, Hormonal Therapy); By Age Group (Infants, Toddlers, Older Children); By End User (Pediatric Hospitals, General Hospitals, Specialty Clinics, Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Undescended Testicle Market is expected to post a steady CAGR of 6.8% , with an estimated market value of USD 460 million in 2024 and a p... Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Ultrasonic Nebulizer Market By Product Type (Tabletop Ultrasonic Nebulizer, Portable Ultrasonic Nebulizer); By Application (COPD, Asthma, Cystic Fibrosis, Others); By End User (Hospitals, Outpatient Clinics, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Ultrasonic Nebulizer Market valued at USD 0.89 billion in 2024 and projected to hit USD 1.41 billion by 2030 at 8.0% CAGR, driven by ultrasonic ne... Read More

Published Date: JAN-2026 | No Of Pages:192 | $ 4485

Spina Bifida In-Utero Market By Procedure Type (Open Fetal Surgery, Minimally Invasive/Fetoscopic Repair); By Application (Myelomeningocele Correction, Other Neural Tube Defects); By End User (Academic Hospitals, Children’s Hospitals, Regional Perinatal Centers, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Spina Bifida In-Utero Market will expand at a consistent CAGR of 8.6%, moving from USD 397 million in 2024 to USD 650 million by 2030, propelled by Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Sodium Channel Blockers Market By Product Type (Anticonvulsants, Antiarrhythmic Drugs, Local Anesthetics, Others); By Application (Neurology, Cardiology, Pain Management, Others); By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Long-term Care Facilities); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sodium Channel Blockers Market expanding at 8.3% CAGR, supported by sodium channel blockers, neurology treatments, cardiology drugs, Read More

Published Date: JAN-2026 | No Of Pages:177 | $ 4485

Sialorrhea Treatment Market By Treatment Type (Oral Anticholinergic Medicines, Botulinum Toxin Injections, Surgical and Interventional Procedures, Radiotherapy); By Disease Indication (Parkinson’s Disease, Cerebral Palsy, Amyotrophic Lateral Sclerosis, Stroke and Traumatic Brain Injury, Clozapine-Induced Sialorrhea, Neurodevelopmental Disorders); By Patient Group (Pediatric Patients, Adult Patients); By End User (Hospitals, Neurology Clinics, Pediatric Specialty Clinics, Rehabilitation Centers, ENT Clinics, Long-Term Care and Home-Care Settings); By Region, Segment Revenue Estimation, Forecast, 2026–2032

Sialorrhea Treatment Market Gains from Neurologic Disease Burden, Botulinum Toxin Access, and Pediatric Drooling Control

The Global Sialorrhea Treatment Market was valued at USD 734 million in 2025 and is projected to reach USD 1.08 billion by 2032, growing at a CAGR ... Read More

Published Date: JUL-2026 | No Of Pages:192 | $ 4485

Sacroiliac Joint Fusion Market By Procedure Type (Minimally Invasive SI Joint Fusion, Open SI Joint Fusion); By Component (Implants, Instrumentation, Navigation & Imaging Systems); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sacroiliac Joint Fusion Market valued at USD 360 million in 2024 and projected to hit USD 525 million by 2030 at 6.5%, CAGR, with rising healthcar... Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Robotic Medical Imaging Market By Imaging Modality (MRI, CT, Ultrasound, Others); By Application (Interventional Radiology, Neurosurgery, Orthopedics, Oncology, Cardiovascular); By End User (Tertiary Hospitals, Specialty Clinics, Outpatient Imaging Centers, Military/Mobile Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Robotic Medical Imaging Market valued at USD 4.1 billion in 2024 and projected to reach USD 7.2 billion by 2030 at 9.3% CAGR, driven by robotic me... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Patient Risk Stratification Market By Solution Type (AI-Driven Platforms, Rules-Based Systems, Integrated EHR Modules); By Application Area (Chronic Disease Management, Readmission Prevention, Population Health, Oncology); By End User (Hospitals and Health Systems, Payers and Insurers, Government Agencies, ACOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Patient Risk Stratification Market growing at 11.6% CAGR, leveraging patient risk stratification market, healthcare analytics, predictive analytic... Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Ophthalmoplegia Market By Type (External Ophthalmoplegia, Internal Ophthalmoplegia, Complete Ophthalmoplegia); By Cause (Stroke, Diabetes, Autoimmune Disorders, Mitochondrial Disease, Tumors); By Treatment (Pharmacological, Surgical, Botulinum Toxin, Rehabilitation); By End User (Tertiary Hospitals, Specialty Clinics, Rehabilitation Centers, Surgical Eye Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ophthalmoplegia Market is expected to grow at a steady CAGR of 5.8%, valued at USD 1.2 billion in 2024, and projected to surpass USD 1.7 billion by 2030, ... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Nanobodies Market By Application (Therapeutics, Diagnostics, Research Tools); By Therapeutic Area (Oncology, Autoimmune Diseases, Neurology, Infectious Diseases); By End User (Biopharma Companies, Academic Research Institutes, Diagnostic Labs, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nanobodies Market grows from USD 1.4 billion in 2024 to USD 3.1 billion by 2030 at 13.8% CAGR, supported by camelid antibody technology, ... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Muckle Wells Syndrome Market By Therapy Type (IL-1 Inhibitors, Corticosteroids & NSAIDs, Emerging Agents); By Route of Administration (Injectable, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Muckle Wells Syndrome Market is anticipated to see steady but specialized growth over the forecast period, with an CAGR of 6.5% . The mar... Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Intracranial Hemorrhage Diagnosis Market By Imaging Modality (CT, MRI, Ultrasound, Nuclear Imaging); By Type of Hemorrhage (Intracerebral, Subarachnoid, Subdural, Epidural, Intraventricular); By End User (Hospitals & Trauma Centers, Stroke Clinics, Diagnostic Imaging Centers, Mobile Stroke Units); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Intracranial Hemorrhage Diagnosis Market is projected to grow at a CAGR of 6.7% , with an estimated value of around USD 1.1 billion in 2024Read More

Published Date: JAN-2026 | No Of Pages:161 | $ 4485

ICU Beds Market By Product Type (Electric ICU Beds, Manual ICU Beds, Hybrid/Powered Beds); By Technology (Basic ICU Beds, Advanced ICU Beds); By End User (Hospitals, Specialty Clinics, Long-Term Care & Rehabilitation Centers, Ambulatory & Emergency Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global ICU Beds Market expanding from USD 4.6 billion in 2024 to USD 7.1 billion by 2030, with CAGR of 7.4%, driven by ICU beds market, ... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Hyperhidrosis Treatment Market By Treatment Type (Botox Injections, Iontophoresis, Microwave Therapy, Surgical Procedures, Topical Treatments); By End User (Dermatology Clinics, Hospitals, Outpatient Clinics, Home Care); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hyperhidrosis Treatment Market is expected to expand at a CAGR of 7.5% from 2024 to 2030, increasing from $4.1 billion in 2024 to $6.8 Billion in 2030, fu... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Human Osteoblasts Market by Type (Primary Osteoblasts, Induced Osteoblasts, Stem Cell-Derived Osteoblasts); By Application (Bone Regeneration, Osteoporosis Treatment, Fracture Healing, Bone Cancer Research); By End-User (Hospitals, Research Institutes, Biotech Companies, Imaging Centers, ASCs); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Human Osteoblasts Market is projected to grow from an estimated USD 3.5 billion in 2024 to USD 6.5 billion by 2030, with a CAGR of 10% during this period, driven... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

House Dust Mite Allergy Market By Product Type (Antihistamines, Intranasal Corticosteroids, Immunotherapy [SCIT, SLIT], Biologics); By Route of Administration (Oral, Nasal, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global House Dust Mite Allergy Market valued at USD 1.92 billion in 2024 and projected to reach USD 2.94 billion by 2030 at 6.4%, CAGR, reflecting market... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Homozygous Familial Hypercholesterolemia Market By Drug Class (Statins, PCSK9 Inhibitors, Lomitapide, Gene Therapy, RNA-based Therapeutics); By Route of Administration (Oral, Subcutaneous, Intravenous); By Patient Age Group (Pediatric, Adult); By End User (Specialty Lipid Clinics, Academic Hospitals, General Hospitals, Payers/Managed Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Homozygous Familial Hypercholesterolemia Market is set to witness CAGR of 11.3%, growing from $1.14 billion in 2024 to $2.15 billion by 2030, driven by Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Histoplasmosis Treatment Market By Drug Type (Azoles, Polyenes, Adjunctive Therapies); By Route of Administration (Oral, Intravenous); By Patient Group (Immunocompromised, Immunocompetent); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Histoplasmosis Treatment Market will grow at a CAGR of 6.3%, with a valuation of USD 1.6 billion in 2024 and expected to hit USD 2.3 billion by 2030, supp... Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Group B Streptococcus Infection Treatment Market By Drug Class (Beta-lactam Antibiotics, Clindamycin & Alternatives, Pipeline Therapies); By Route of Administration (Intravenous, Oral); By End User (Hospitals, Maternity Clinics & Birthing Centers, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Group B Streptococcus (GBS) Infection Treatment Market is set to witness a steady CAGR of 5.4% , valued... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Nanoparticle-Based Drug Delivery Systems Market By Drug Type (Chemotherapy Drugs, Gene Therapy Drugs, Protein and Peptide Drugs); By Technology Type (Liposomes, Polymeric Nanoparticles, Solid Lipid Nanoparticles); By Application (Cancer Treatment, Neurological Disorders, Infectious Diseases); By End User (Children’s Hospitals, General Hospitals, Research Institutions, Pharmaceutical Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Nanoparticle-Based Drug Delivery Systems Market is set to grow at a 12.6% CAGR, expanding from USD 4.2 billion in 2024 to USD 8.6 billion by 2030<... Read More

Published Date: SEP-2025 | No Of Pages:170 | $ 4485

Glaucoma Drainage Devices (GDDs) Market By Product Type (Valved Glaucoma Drainage Devices, Non-Valved Glaucoma Drainage Devices, Adjustable Glaucoma Drainage Devices); By Application (Refractory Primary Open-Angle Glaucoma, Neovascular Glaucoma, Uveitic Glaucoma, Pediatric and Congenital Glaucoma, Other Secondary and Complex Glaucoma); By End User (Hospitals, Specialty Eye Hospitals and Clinics, Ambulatory Surgical Centers, Academic and Research Institutions); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Segment Revenue Estimation, Forecast, 2026–2032

Glaucoma Drainage Devices Market: Durable Pressure Control Is Expanding the Role of Tube Shunts

The Global Glaucoma Drainage Devices (GDDs) Market is valued at USD 991 million in 2025 and is projected to reach USD 1.73 billion by 2032, growing at a CAGR of 8.3%, accor... Read More

Published Date: JUL-2026 | No Of Pages:182 | $ 4485

Gingival Recession Market By Product Type (Soft Tissue Grafts, Regenerative Biomaterials, Dental Membranes, Growth Factors); By Treatment Approach (Surgical Flap Procedures, Connective Tissue Grafts, Guided Tissue Regeneration); By End User (Private Clinics, Hospitals, Academic Institutions, Specialty Periodontal Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gingival Recession Market is expected to grow steadily, with an valuation of 1.9 billion USD in 2024 and projected to reach 2.8 billion USD by 2030 . This reflects a Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Needle-Free Drug Delivery Devices Market By Device Type (Jet Injectors, Transdermal Patches, Inhaler-Based Systems, Microneedle-Based Systems); By Application (Vaccination, Pain Management, Insulin Delivery, Cosmetic Dermatology, Oncology & Autoimmune Disorders); By End User (Hospitals & Clinics, Home Care Settings, Ambulatory Surgical Centers, Cosmetic & Dermatology Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Needle-Free Drug Delivery Devices Market propelled by needle-free injectors, transdermal therapeutic systems, biopharmaceutical injection devices, Read More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Oligonucleotide Therapeutics Market By Drug Type (Antisense Oligonucleotides, Small Interfering RNAs, Aptamers, Others); By Application (Rare Genetic Disorders, Oncology, Metabolic/Liver Diseases, Infectious Diseases, Ophthalmology); By Route of Administration (Subcutaneous, Intrathecal, Intravenous, Others); By End User (Academic Hospitals, Specialty Clinics, Outpatient Centers, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Oligonucleotide Therapeutics Market is expected to witness a strong CAGR of 14.6%, valued at USD 8.1 billion in 2024 and projected to surpass USD 18.4 billion by 2... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Animal Hormones Market By Product Type (Growth Promoters, Reproductive Hormones, Metabolic Hormones); By Species (Cattle, Swine, Poultry, Companion Animals, Aquaculture); By Route of Administration (Injectables, Implants, Oral); By Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, Online, Direct-to-Farm); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Animal Hormones Market will witness a steady CAGR of 5.9%, valued at around USD 2.9 billion in 2024, and is expected to reach nearly USD 4.1 billi... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Adipose-derived Stem Cell Market By Cell Type (Autologous, Allogenic); By Application (Regenerative Medicine, Aesthetic Medicine, Wound Healing & Tissue Repair, Drug Discovery & Research); By End User (Hospitals & Specialty Clinics, Cosmetic & Aesthetic Clinics, Research Institutions, Biotech & Cell Therapy Developers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Adipose-Derived Stem Cell Market grows at 9.6% CAGR, rising from USD 1.6 billion in 2024 to USD 2.8 billion by 2030, driven by adipose stem cells<... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Presbyopia Correction Device Market By Product Type (Intraocular Lenses, Corneal Inlays, Light Adjustable Lenses, Corneal Refractive Procedures); By Technology (Monovision Correction, Multifocal & EDOF Platforms, Wavefront-Guided Systems); By End User (Hospitals, Specialty Eye Clinics, Ambulatory Surgical Centers, Retail & Optometry Chains); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Presbyopia Correction Device Market valued at USD 5.1 billion in 2024 and projected to reach USD 7.8 billion by 2030 at 7.3% CAGR, reflecting glob... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Veterinary Antihistamines Market By Product Type (H1 Antagonists, H2 Antagonists, Combination Antihistamines); By Route of Administration (Oral, Injectable, Topical); By Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Veterinary Antihistamines Market projected to reach USD 1.07 billion by 2030 from USD 720 million in 2024 at expanding 5.8% CAGR, driven by veteri... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Urology Disposable Market By Product Type (Urinary Catheters, Drainage Bags, Ureteral Stents, Guidewires & Access Sheaths, Irrigation Sets); By Application (Urinary Incontinence, BPH, Urinary Retention, Urolithiasis, Spinal/Neurogenic Disorders); By End User (Hospitals, Urology Clinics, Ambulatory Surgical Centers, Home Healthcare, Long-Term Care Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Urology Disposable Market fueled by medical disposables, urology devices, hospital consumables, infection prevention technology, ... Read More

Published Date: JAN-2026 | No Of Pages:185 | $ 4485

Familial Adenomatous Polyposis Treatment Market By Treatment Type (Pharmacologic Therapy, Surgical Intervention, Gene Therapy); By End User (Hospitals, Specialty Clinics, Research Centers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Familial Adenomatous Polyposis Treatment Market is poised to grow at a robust CAGR of 8.2%, valued at USD 1.3 billion in 2024 and projected to reach USD 2.1 billio... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Collagen Filler Market By Product Type (Animal-Based Collagen Fillers, Synthetic/Recombinant Collagen Fillers); By Application (Facial Aesthetics, Scar Correction, Lip Enhancement, Hand Rejuvenation, Post-Surgical Reconstruction); By End User (Dermatology Clinics, Plastic Surgery Centers, Med-Spas, Wellness Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Collagen Filler Market valued at USD 1.4 billion in 2024 and projected to reach USD 2.3 billion by 2030 at 8.6% CAGR, driven by collagen filler ma... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Long Acting Drugs Market By Drug Type (Long Acting Injectables, Extended-Release Oral Tablets, Implants and Inserts, Transdermal Patches and Films); By Therapeutic Application (Psychiatry & Neurology, Infectious Diseases, Oncology, Endocrinology & Diabetes, Women’s Health, Pain & Addiction); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics & Public Health Programs, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Long Acting Drugs Market valued at $64.3 billion in 2024 and projected to reach $96.2 billion by 2030 at 6.9% CAGR, highlighting injectable drug f... Read More

Published Date: JAN-2026 | No Of Pages:177 | $ 4485

Ophthalmic Disposables Market By Product Type (Surgical Disposables, Diagnostic Disposables, General Ophthalmic Consumables); By Application (Surgery, Diagnostics, Routine Eye Examinations); By End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ophthalmic Disposables Market is valued at USD 3.2 billion in 2024 and projected to reach USD 4.4 billion by 2030 at 5.6% CAGR, driven by eye... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Recurrent Pericarditis Market by Treatment Type (Biologic Therapies, NSAIDs, Colchicine, Corticosteroids, Surgical Interventions); By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Recurrent Pericarditis Market will expand steadily at a CAGR of 6.5%, reaching $2.1 billion by 2030 from $1.2 billion in 2024, supported by cardia... Read More

Published Date: JAN-2026 | No Of Pages:192 | $ 4485

Postoperative Pain Management Market By Product Type (Non-Opioid Analgesics, Opioid Analgesics, Local Anesthetics, Adjuvant Therapies, Devices, Digital Solutions); By Route of Administration (Oral, Intravenous, Regional, Transdermal, Others); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Postoperative Pain Management Market is set to expand at a CAGR of 6.1%, with a market value of USD 13.2 billion in 2024, projected to reach USD 18.8 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Bladder Cancer Therapeutics Market By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, Intravesical Therapy, Combination Therapy); By Disease Stage (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer, Metastatic Bladder Cancer); By Route of Administration (Intravenous, Oral, Intravesical); By End User (Hospitals and Cancer Centers, Specialty Urology Clinics, Ambulatory Surgical Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bladder Cancer Therapeutics Market will witness steady expansion at a CAGR of 7.6%, valued at USD 4.2 billion in 2024 and projected to reach USD 6.52 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Antibiotic-Coated Surgical Implant Drug Market By Implant Type (Orthopedic Implants, Cardiovascular Implants, Trauma Fixation Implants, Neurosurgical & Spinal Implants, Dental Implants); By Coating/Drug Platform (Gentamicin Coatings, Vancomycin-Loaded Systems, Minocycline-Rifampin Envelopes, Dual-Antibiotic Bone Cement, Antibiotic-Loaded Hydrogel Coatings, Point-of-Care Polymeric Coatings, Silver & Non-Antibiotic Antimicrobial Coatings); By End User (Hospitals & Trauma Centers, Ambulatory Surgical Centers, Orthopedic Specialty Clinics, Cardiac Electrophysiology Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Antibiotic-Coated Surgical Implant Drug Market Overview: Local Antibacterial Protection Becomes a Surgical Implant Differentiator

The Global Antibiotic-Coated Surgical Implant Drug Market was valued at USD 2.3 billion in 2025 and projected to reach USD 3.65 billion by... Read More

Published Date: JUN-2026 | No Of Pages:168 | $ 4485

Topical Corticosteroids Market By Product Type (Low-Potency, Medium-Potency, High-Potency); By Formulation (Creams, Ointments, Sprays, Foams, Liposome-Based); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Supermarkets); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Topical Corticosteroids Market is estimated at USD 8.7 billion in 2024 and is projected to reach USD 12.6 billion by 2030, expanding at a CAGR of ... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Migraine Nasal Spray Market By Product Type (Branded, Generic); By Drug Class (Triptans, Gepants, Ditans); By Route of Administration (Nasal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By End User (Hospitals, Specialty Clinics, Adults, Adolescents, Geriatric); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Migraine Nasal Spray Market valued at $795 million in 2024 and projected to reach $1.46 billion by 2030 at 10.6% CAGR, driven by migraine treatmen... Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Veterinary Corticosteroids Market By Product Type (Dexamethasone, Prednisone, Hydrocortisone, Methylprednisolone, Prednisolone); By Route of Administration (Oral, Injectable, Topical, Inhalable); By Animal Type (Companion Animals, Livestock, Equine); By Distribution Channel (Veterinary Hospitals & Clinics, Retail Veterinary Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Veterinary Corticosteroids Market expanding at 5.6% CAGR, driven by market growth, veterinary corticosteroids, market size, indus... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Dexamethasone Market By Product Type (Injectable, Oral Tablets, Ophthalmic, Topical); By Route of Administration (Oral, Intravenous, Intramuscular, Intraocular, Topical); By Application (Oncology Support, Inflammatory & Autoimmune Diseases, Respiratory Conditions, Allergic Reactions, COVID-19 & Critical Care); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dexamethasone Market will witness a CAGR of 6.5%, valued at USD 2.8 billion in 2024 and expected to reach USD 4.1 billion by 2030, supported by ph... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Pediatric Medical Devices Market By Product Type (Diagnostic Devices, Therapeutic Devices, Surgical Instruments, Assistive & Monitoring Equipment); By Application (Cardiology, Neonatology, Orthopedics, Oncology, Respiratory Disorders, Endocrinology); By End User (Children’s Hospitals, General Hospitals, Ambulatory Surgical Centers, Homecare & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pediatric Medical Devices Market supported by pediatric healthcare devices, diagnostic monitoring systems, neonatal ICU equipment, medical technol... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

At-Home Molecular Testing Market By Test Type (Infectious Disease Testing, Oncology Monitoring, Genetic Screening, Women’s Health); By Technology (Isothermal Amplification, CRISPR Diagnostics, Real-Time PCR, Microfluidic Platforms); By Sample Type (Nasal Swab, Saliva, Capillary Blood); By Distribution Channel (Retail Pharmacies, Online Platforms, Telehealth Networks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global At-Home Molecular Testing Market will grow at a strong CAGR of 11.8%, valued at USD 3.6 billion in 2024, and expected to reach USD 7.1 billion by 2030, ac... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Cetuximab Market By Indication (Metastatic Colorectal Cancer, Head & Neck Squamous Cell Carcinoma); By Route of Administration (Intravenous); By Distribution Channel (Hospital Pharmacies, Specialty Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cetuximab Market will expand at an estimated CAGR of 5.6%, rising from a value of USD 1.45 billion in 2024 to nearly USD 2.01 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Phentermine Hydrochloride Market By Product Type (Tablets, Capsules, Orally Disintegrating Tablets); By Route of Administration (Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Phentermine Hydrochloride Market is projected to grow at a CAGR of 4.6%, valued at $520 million in 2024, expected to reach $682 million by 2030, driven by... Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Plastic Vials Market By Material Type (Polypropylene, Polyethylene, Polyethylene Terephthalate, Cyclic Olefin Polymer, Others); By Capacity (Less than 5 mL, 5–20 mL, Above 20 mL); By End Use (Pharmaceuticals, Diagnostics, Nutraceuticals & Personal Care, Public Health & NGO Use); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Plastic Vials Market is projected to grow at a CAGR of 5.6%, with an estimated value of USD 2.7 billion in 2024, expected to reach around USD 3.9 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Smart Pill Boxes Market By Product Type (Automated Dispensers, Manual Smart Boxes); By Connectivity (Bluetooth-Enabled, Wi-Fi / Cellular-Connected); By End User (Home Healthcare, Hospitals & Clinics, Long-Term Care Facilities, Pharmacies); By Distribution Channel (Online Retailers, Hospitals & Clinics, Third-Party Services); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Smart Pill Boxes Market is projected to expand steadily between 2024 and 2030, growing at a CAGR of 8.1%. The market is valued at approximately USD 1.6 billion in ... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Giant Cell Arteritis Market By Therapy Type (Corticosteroids, Biologics, Supportive Therapies); By Route of Administration (Oral, Injectable [Subcutaneous, Intravenous]); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Giant Cell Arteritis (GCA) Market will witness steady expansion, valued at USD 1.3 billion in 2024 and projected to reach USD 2.1 billion by 2030, growing at a CAG... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Uro-Gynaecological Surgical Devices Market By Product Type (Surgical Meshes, Slings, Laparoscopic Instruments, Robotic Systems, Energy Devices, Ancillary Tools); By Application (Pelvic Organ Prolapse Repair, Urinary Incontinence, Hysterectomy, Uro-gynaecological Cancer Surgery); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Uro-Gynaecological Surgical Devices Market highlighting pelvic floor repair devices, urogynecology surgery tools, surgical implants, healthcare de... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Plant-based Vaccines Market By Vaccine Type (Prophylactic Vaccines, Therapeutic Vaccines); By Target Indication (Influenza, COVID-19, HPV, Zika Virus, Others); By Plant System (Tobacco, Maize, Potato, Tomato, Lettuce); By End User (Public Health Agencies, Hospitals & Clinics, Academic & Research Institutions, Contract Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Plant-Based Vaccines Market is fueled by plant biotechnology, molecular farming vaccines, recombinant protein technology, biopharmaceutical innova... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Giant Papillary Conjunctivitis Market By Treatment Type (Antihistamines & Mast Cell Stabilizers, Corticosteroids, Immunomodulators, Lubricants & Supportive Care); By Route of Administration (Topical Eye Drops, Ophthalmic Inserts, Systemic Therapy); By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Giant Papillary Conjunctivitis (GPC) Market is projected to grow at a CAGR of 6.5% between 2024 and 2030, climbing from an estimated value of USD 1.26 billion in 2024 to a... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Giant Axonal Neuropathy Market By Treatment Type (Gene Therapy, Antisense Oligonucleotides, Supportive & Symptomatic Care); By Route of Administration (Intrathecal, Intravenous, Oral & Others); By End User (Academic & Research Hospitals, Specialty Neurology Clinics, Pediatric Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Giant Axonal Neuropathy (GAN) Market is projected to grow at a CAGR of 19.8% between 2024 and 2030, with an estimated market size of USD 78.2 million in 2024 and reaching ... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Gestational Diabetes Market By Treatment Type (Insulin Therapy, Oral Hypoglycemic Agents, Lifestyle & Nutritional Management); By Diagnostic Approach (OGTT & GCT, HbA1c Testing, Continuous Glucose Monitoring); By End User (Hospitals & Maternity Clinics, Diagnostic Laboratories, Digital Health Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gestational Diabetes Market is projected to grow at a steady CAGR of 6.7%, valued at USD 2.8 billion in 2024 and anticipated to reach USD 4.1 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Gene Therapy in Ophthalmology Market By Therapy Type (Gene Augmentation, Gene Editing, RNA-based Therapy); By Disease Indication (Leber Congenital Amaurosis, Retinitis Pigmentosa, Stargardt Disease, Choroideremia, X-linked Retinoschisis, Wet AMD, Diabetic Macular Edema); By Delivery Method (Subretinal, Suprachoroidal, Intravitreal); By End User (Academic Medical Centers, Specialty Retina Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Gene Therapy In Ophthalmology Market will witness a robust CAGR of 26.5% , valued at USD 1.42 billion in 2024 , and expe... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Frontotemporal Dementia Market By Offering (Diagnostics, Therapeutics, Supportive Care & Long-Term Care Services); By Disease Type (Behavioral-Variant Frontotemporal Dementia, Primary Progressive Aphasia, FTD With Motor Neuron Disease/Movement Disorders, Other FTD Spectrum Disorders); By Diagnostic Modality (Neuroimaging, Genetic Testing & Counseling, Neuropsychological & Language Assessment, CSF/PET/Biomarker Testing); By Genetic Profile (Sporadic FTD, GRN Mutation FTD, C9orf72-Associated FTD, MAPT-Associated FTD); By Treatment Approach (Symptomatic Management & Multidisciplinary Supportive Care, Progranulin Replacement Therapies, GRN Gene Therapy, Other Disease-Modifying Pipeline Therapies); By End User (Hospitals & Memory Clinics, Specialty Neurology Centers, Genetic Testing Laboratories & Counseling Centers, Research Institutes & Clinical Trial Sites, Home Care & Long-Term Support Providers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Frontotemporal Dementia Market: Genetic Diagnosis, Supportive-Care Spending and Progranulin Programs Redefine Commercial Opportunity

The Global Frontotemporal Dementia Market is valued at USD 3.92 billion in 2025 and is projected to reach USD 7.35 billion by 2032, exp... Read More

Published Date: JUL-2026 | No Of Pages:192 | $ 4485

Excessive Daytime Sleepiness Market By Drug Class (Stimulants, Wakefulness-Promoting Agents, Non-Stimulant Therapies, Digital Therapeutics); By Underlying Condition (Obstructive Sleep Apnea, Narcolepsy, Idiopathic Hypersomnia, Shift Work Sleep Disorder); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/Telehealth Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Excessive Daytime Sleepiness Market is anticipated to expand at a CAGR of 8.1%, estimated at $4.3 billion in 2024 and projected to reach $6.8 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Erosive Hand Osteoarthritis Market By Treatment Type (Pharmacological Treatment, Surgical Treatment, Non-Pharmacological Treatment); By End User (Hospitals, Specialty Clinics, Outpatient Care Centers); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Erosive Hand Osteoarthritis Market is poised to grow at a CAGR of 6.3% , reaching an estimated value of USD 1.12 billion by 2030 , up from USD 780... Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Epithelioid Sarcoma Treatment Market By Treatment Modality (Surgery and Reconstruction, Chemotherapy, Radiation Therapy, Targeted/Precision Therapy, Immunotherapy and Clinical Trial-Based Therapy, Supportive Care and Surveillance); By Disease Stage (Localized Resectable Disease, Locally Advanced/Unresectable Disease, Recurrent Disease, Metastatic Disease); By Care Setting/End User (Specialist Sarcoma Centers and Tertiary Cancer Hospitals, General Hospitals and Oncology Clinics, Ambulatory Surgical Centers, Research Institutes and Clinical Trial Sites); By Geography, Segment Revenue Estimation and Forecast, 2026–2032

Epithelioid Sarcoma Treatment Market: Tazverik Withdrawal, Surgery-Led Care, and Biomarker Trials Reset Competition

The Global Epithelioid Sarcoma Treatment Market was valued at USD 1.54 billion in 2025 and is projected to reach USD 3.26 billion by 2032, growing at a ... Read More

Published Date: JUL-2026 | No Of Pages:150 | $ 4485

Emphysema Market By Treatment Type (Inhaled Medications, Biologics, Surgical & Device-Based Interventions, Pulmonary Rehabilitation & Oxygen Therapy); By Route of Administration (Inhalation, Oral, Injectable/Biologic); By End User (Hospitals, Retail Pharmacies, Homecare Providers, Payers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Emphysema Market is projected to grow steadily between 2024 and 2030, valued at USD 6.8 billion in 2024 and forecasted to reach USD 9.7 billion by 2030 , ... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Ebola Fever Therapeutics Market By Product Type (Monoclonal Antibody Therapies, Antiviral Agents, RNA-Based Therapeutics, Supportive Therapies & Immunomodulators); By Route of Administration (Intravenous, Oral, Intramuscular/Subcutaneous); By Distribution Channel (Government & Public Health Procurement, NGOs & Humanitarian Agencies, Hospital Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Ebola Fever Therapeutics Market is projected to expand steadily at a CAGR of 6.9% , growing from an estimated USD 1.02 billion in... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Drug Infusion Systems Market By Product & System Component (Large Volume Infusion Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Elastomeric Pumps, Insulin Pumps, Patient-Controlled Analgesia Pumps, Implantable Infusion Pumps, Wearable Infusion Devices, Infusion Consumables & Accessories, Infusion Software & Services); By Technology (Conventional Infusion Systems, Smart Infusion Pumps with Dose-Error-Reduction Systems, Wireless/Connected Infusion Systems, EHR-Integrated Infusion Systems, Closed-Loop/Automated Infusion Platforms); By Application (Critical Care, Oncology, Diabetes Management, Pain Management, Parenteral Nutrition, Infectious Disease Treatment, Specialty Biologics & Immunology, Anesthesia & Perioperative Care, Home & Ambulatory Infusion Therapies); By End User (Hospitals, Ambulatory Infusion Centers, Home Infusion & Home Healthcare Providers, Specialty Clinics, Long-Term Care Facilities, Diabetes Care Users); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Drug Infusion Systems Market: Safety, Smart Pump Optimization, and Home Infusion Drive Growth

The Global Drug Infusion System Market is projected to grow at a CAGR of 8.31%, with a value of USD 14.2 billion in 2025 and estimated to reach USD 24.8 billion by 2032, acco... Read More

Published Date: JUL-2026 | No Of Pages:157 | $ 4485

Diverticulitis Market By Treatment Type (Medical, Surgical); By Product Type (Pharmaceuticals, Nutritional Therapies, Surgical Devices, Digital Monitoring Tools); By Disease Type (Uncomplicated, Complicated); By End User (Hospitals, Gastroenterology Clinics, Ambulatory Surgical Centers, Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diverticulitis Market expanding from USD 4.1 billion in 2024 to USD 6.0 billion by 2030 at a CAGR of 6.5%, reflecting market growth, Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Diarrhea Therapeutics Market By Drug Class (Oral Rehydration Salts, Anti-Motility Agents, Antibiotics, Probiotics, Zinc Supplements); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diarrhea Therapeutics Market will witness a steady CAGR of 5.8% , valued at USD 9.6 billion in 2024 and expected to reac... Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Continuous Bioprocessing Market By Product Type (Upstream Bioreactors, Continuous Chromatography, TFF Systems, PAT, Single-Use Systems, Automation Software); By Application (Clinical Production, Commercial Manufacturing, R&D, Process Development); By End User (Pharmaceutical Companies, Biotech Startups, CDMOs, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Continuous Bioprocessing Market expanding from USD 4.3 billion in 2024 to USD 10.2 billion by 2030, with a CAGR of 15.1%, fueled by continuous bio... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Congenital Adrenal Hyperplasia Treatment Market By Drug Type (Glucocorticoids, Mineralocorticoids, Steroidogenesis Inhibitors, CRF1 Receptor Antagonists); By Route of Administration (Oral, Injectable, Transdermal); By Age Group (Pediatric, Adolescent, Adult); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Congenital Adrenal Hyperplasia (CAH) Treatment Market will register growth at a CAGR of 6.8%, expanding from USD 472 million in 2024 to USD 703 million by 2030Read More

Published Date: JAN-2026 | No Of Pages:185 | $ 4485

Clinically Isolated Syndrome Market By Drug Class (Injectables, Oral Therapies, Monoclonal Antibodies); By Diagnostic Tool (MRI, CSF Analysis, Optical Coherence Tomography, Evoked Potentials); By Patient Type (Adults, Pediatric Onset, High-Risk Patients); By End User (Neurology Clinics, Imaging Centers, Hospitals, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Clinically Isolated Syndrome (CIS) Market is projected to grow at a steady CAGR of 6.5% , reaching an estimated value of $2.6 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:155 | $ 4485

Clear Cell Ovarian Cancer Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Surgical Intervention); By Disease Stage (Stage I–II, Stage III–IV); By End User (Academic & Research Hospitals, Cancer Specialty Centers, General Hospitals, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Clear Cell Ovarian Cancer Market is projected to expand at a CAGR of 6.8%, reaching approximately USD 1.9 billion by 2030, up from an estimated USD 1.3 billion in ... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Chronic Traumatic Encephalopathy Market By Diagnostic Type (Neuroimaging, Blood Biomarkers, Neurocognitive Tools); By Intervention Type (Symptom Management Drugs, Neuroprotective Therapies, Behavioral and Cognitive Therapy); By End User (Neurology Clinics, Sports Medicine Institutions, Veteran Health Systems, Academic Research Institutes); By Geography, Segment Revenue Estimation and Forecast, 2026–2032

Chronic Traumatic Encephalopathy Market: Living-Diagnosis Bottleneck Shifts Revenue Toward Biomarkers, Exposure Reduction, and Long-Term Neurological Care

The Global Chronic Traumatic Encephalopathy Market is projected to expand at a CAGR of 9.1%, rising from USD 1.20... Read More

Published Date: JUL-2026 | No Of Pages:192 | $ 4485

Chronic Myelomonocytic Leukemia Market By Treatment Type (Hypomethylating Agents, Targeted Therapies, Stem Cell Transplantation, Supportive Care); By Route of Administration (Injectable, Oral); By End User (Academic Medical Centers, Community Oncology Clinics, Transplant Centers, Specialized Hematology Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Myelomonocytic Leukemia (CMML) Market was valued at approximately USD 720 Million in 2024 and is projected to surpass USD 1.1 Billion by 2030, expanding at aRead More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Chronic Idiopathic Urticaria Treatment Market By Drug Class (Antihistamines, Monoclonal Antibodies, Leukotriene Receptor Antagonists, Immunosuppressants); By Route of Administration (Oral, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Idiopathic Urticaria Treatment Market is anticipated to grow from USD 4.8 billion in 2024 to around USD 7.6 billion by 2030, achieving a CAGR of 7.9% (2024... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Cervical Intraepithelial Neoplasia Market By CIN Grade (CIN I, CIN II, CIN III); By Diagnostic Method (Pap Smear, HPV Testing, Colposcopy, Biomarker Triage); By Treatment (Cryotherapy, LEEP, Cold Knife Conization, Immunotherapy); By End User (Hospitals, Specialty Clinics, Diagnostic Labs, Community Health Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cervical Intraepithelial Neoplasia (CIN) Market will witness a steady CAGR of 6.8%, valued at USD 1.32 billion in 2024, and projected to ... Read More

Published Date: JAN-2026 | No Of Pages:185 | $ 4485

Cerebrotendinous Xanthomatosis Market By Treatment Type (Chenodeoxycholic Acid (CDCA) / Chenodiol, Adjunctive Therapies, Pipeline/Investigational Drugs); By Route of Administration (Oral, Future-IV/Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/Compounding Pharmacies); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2026–2032

Cerebrotendinous Xanthomatosis Market - Market Size, Diagnosed-Prevalence Economics, CDCA Treatment Pathway, Pipeline Catalysts, Rare-Disease Commercial Positioning and 2032 Outlook  – (Updated On: 31-Aug-2026)

 

Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Cell Migration and Cell Invasion Assay Market By Assay Type (2D Assays, 3D Assays); By Application (Cancer Research, Stem Cell & Regenerative Medicine, Immunology, Wound Healing & Tissue Engineering, Neurology & Developmental Biology); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cell Migration And Cell Invasion Assay Market is projected to reach $1.1 billion by 2030 , up from $ 680.0 million in 2024 , growing at a CAGR of 8.4% dur... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Carotid Artery Stents Market By Type (Self-Expanding Stents, Balloon-Expandable Stents); By Material (Nitinol, Stainless Steel, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Carotid Artery Stents Market will witness a steady CAGR of 7.1% , valued at USD 1.18 billion in 2024 , and projected to reach nearly USD 1.78 bill... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Cardiovascular Calcification Market By Product Type (Imaging Systems, Atherectomy Devices, Drug-Eluting Stents, Transcatheter Heart Valves); By Application (Coronary Artery Disease, Aortic Valve Stenosis, Peripheral Artery Disease, CKD-Related Vascular Calcification); By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Clinics, Dialysis & Nephrology Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiovascular Calcification Market is projected to rise at a CAGR of 6.5%, valued at USD 2.9 billion in 2024 and expected to reach USD 4.3 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Cannabis Use Disorder Market By Treatment Type (Pharmacological, Non-Pharmacological); By Delivery Channel (Outpatient Clinics, Digital Therapeutics, Primary Care, University Programs); By Patient Demographics (Age Group, Gender); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Use Disorder Market is projected to reach $3.1 billion in 2030 , up from an estimated $1.8 billion in 2024 , growing at a CAGR of 9.4% during the... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Bronchiolitis Obliterans Syndrome Market By Treatment Type (Immunosuppressants, Corticosteroids, Macrolides, Antifibrotics); By Application (Lung Transplant-Associated BOS, HSCT-Associated BOS); By Route of Administration (Oral, Inhalation, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bronchiolitis Obliterans Syndrome Market will grow at a CAGR of 6.5% , valued at nearly USD 1.42 billion in 2024 and projected to reach around USD 2.08 billion by ... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Bronchial Spasm Market By Drug Type (Short-acting β2-Agonists, Long-acting Bronchodilators, Anticholinergics, Leukotriene Receptor Antagonists); By Route of Administration (Inhaled [MDI, DPI], Nebulized, Oral, Others); By End User (Hospitals, Specialty Clinics, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bronchial Spasm Market is projected to grow at a steady CAGR of 6.4% , increasing from a market value of USD 1.42 billion in 2024 to USD 2.07 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Blastomycosis Treatment Market By Treatment Type (Antifungal Drugs, Surgical Intervention); By End-User (Hospitals, Outpatient Clinics, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Blastomycosis Treatment Market is valued at USD 3.4 billion in 2024 and is expected to reach USD 5.7 billion by 2030, growing at a Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

BK Virus Infection Market By Product Type (Diagnostic Tests, Therapeutic Solutions); By Application (Organ Transplants, Immunocompromised Patients); By End-User (Hospitals & Transplant Centers, Diagnostic Laboratories, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global BK Virus Infection Market is valued at approximately USD 500 million in 2024, projected to reach USD 750 million by 2030, progressing at a CAGR of 7% from 2024 to ... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Bacterial Vaginosis Treatment Market By Treatment Type (Antibiotic Treatments, Probiotics-based Therapy, Topical Treatments, Oral Medications); By End-User (Hospitals & Clinics, Retail Pharmacies, Online Platforms, Diagnostic Imaging Centers, Gynecologists & General Practitioners); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bacterial Vaginosis Treatment Market will witness steady growth, with a projected CAGR of 5.5% from 2024 to 2030. The market was valued at approximately USD 1.3 bi... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Asperger Syndrome Treatment Market By Treatment Type (Behavioral and Psychological Therapy, Speech and Occupational Therapy, Pharmacological Management, Digital Therapeutics and Assistive Technologies); By Age Group (Children, Adolescents, Adults); By End User (Multidisciplinary Specialty Clinics, Hospitals and Diagnostic Centers, Educational Institutions, Home-Based and Teletherapy Platforms); By Geography, Segment Revenue Estimation and Forecast, 2026–2032

Asperger Syndrome Treatment Market: Mental Health Care, Adult Diagnosis, and Multidisciplinary Services Reshape Commercial Demand

The Global Asperger Syndrome Treatment Market was valued at USD 2.41 billion in 2025 and is projected to reach USD 3.67 billion by 2032, e... Read More

Published Date: JUL-2026 | No Of Pages:157 | $ 4485

Arteriovenous Malformations Market By Treatment Type (Embolization, Stereotactic Radiosurgery, Microsurgical Resection, Pharmacological Management); By Diagnostic Modality (DSA, MRI/MRA, CT Angiography, Functional Imaging); By Anatomical Location (Cerebral AVMs, Spinal AVMs, Peripheral AVMs, Visceral AVMs); By End User (Tertiary Hospitals, Academic Centers, General Hospitals, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Arteriovenous Malformations (AVM) Market is projected to grow at a 6.4% CAGR, rising from USD 2.7 billion in 2024 to USD 4.1 billion by 2030, driven by neurovascular treat... Read More

Published Date: JAN-2026 | No Of Pages:170 | $ 4485